TRIM44 was verified to be participated in the resistance of cisplatin in lung adenocarcinoma via deubiquitinating the K48-linked polyubiquitin chain with the ZnF UBP domain [23]. This evidence concerns the gene TRIM44 and lung adenocarcinoma.